Clinical trial
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer…
NCT00017576 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00017576 |
|---|---|
| Title | Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | Phase II Study of Calcitrol Enhanced Carboplatin in Hormone Refractory Prostate Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, carboplatin |
| Enrollment | 19 |
| Start date | Dec 1, 2000 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jan 8, 2004 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: